This medication may infrequently cause or worsen a certain heart problem (congestive heart failure). Tell your doctor right away if you notice any symptoms of heart failure, including: swelling of the hands/feet, unusual/sudden weight gain, trouble breathing, or unusual tiredness.
See also Warning section.
Sore throat, muscle pain, weight gain, or tooth problems may occur. If any of these effects persist or...
Read moreThe commissioner of the Food and Drug Administration yesterday informed a hearing of the House Committee on Oversight and Government Reform... Read more »
It's not quite fall, yet already there are two more studies adding to the whole Avandia/Actos/heart risks debate that's been rising... Read more »
The April 28 issue of the Archives of Internal Medicine has unsettling news for people with diabetes and osteoporosis: The popular diabetes... Read more »
It may be safe to use Januvia in 2014. It isn’t now, says Public Citizen, a watchdog group founded by Ralph Nader.We should wait at least... Read more »
This is a study to compare a combination of the new drug SYR-322 and Actos with each medication alone in people with Type 2 diabetes. This... Read more »
The Food and Drug Administration has approved Duetact, a new drug to treat Type 2 diabetes. Duetact combines two existing diabetes drugs, Actos... Read more »
The Food and Drug Administration has approved Januvia (sitagliptin), the first dipeptidyl peptidase-4 (DPP-4) inhibitor for Type 2 diabetes. The new... Read more »
The Food and Drug Administration (FDA) has requested a black box warning on the labels of Avandia and Actos. Both diabetes meds have been linked to... Read more »
Drugmaker Takeda has dropped development of a medication that combined Actos with TAK-536. The combination med was in Phase III clinical trials in... Read more »